NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 48 filers reported holding NEOS THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q3 2020 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q2 2020 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q1 2020 | $1,000 | -50.0% | 1,000 | 0.0% | 0.00% | – |
Q4 2019 | $2,000 | -97.8% | 1,000 | -98.4% | 0.00% | – |
Q3 2019 | $91,000 | +11.0% | 61,438 | -2.8% | 0.00% | – |
Q2 2019 | $82,000 | -49.1% | 63,234 | +2.8% | 0.00% | – |
Q1 2019 | $161,000 | +61.0% | 61,496 | +1.8% | 0.00% | – |
Q4 2018 | $100,000 | -67.1% | 60,438 | -3.4% | 0.00% | – |
Q3 2018 | $304,000 | +3.4% | 62,571 | +32.9% | 0.00% | – |
Q2 2018 | $294,000 | +1030.8% | 47,097 | +1357.7% | 0.00% | – |
Q1 2018 | $26,000 | +1200.0% | 3,231 | +1424.1% | 0.00% | – |
Q4 2017 | $2,000 | +100.0% | 212 | +186.5% | 0.00% | – |
Q3 2017 | $1,000 | -75.0% | 74 | -86.2% | 0.00% | – |
Q2 2017 | $4,000 | -20.0% | 538 | -16.8% | 0.00% | – |
Q1 2017 | $5,000 | +25.0% | 647 | +6.2% | 0.00% | – |
Q4 2016 | $4,000 | -85.7% | 609 | -85.9% | 0.00% | – |
Q3 2016 | $28,000 | -34.9% | 4,329 | -6.0% | 0.00% | – |
Q2 2016 | $43,000 | -25.9% | 4,606 | -15.0% | 0.00% | – |
Q1 2016 | $58,000 | -24.7% | 5,419 | +1.4% | 0.00% | – |
Q4 2015 | $77,000 | +2466.7% | 5,346 | +3440.4% | 0.00% | – |
Q3 2015 | $3,000 | – | 151 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|